Liposuction Surgery Devices Market Trends

Growth Drivers

• Higher incidence of metabolic disorders and quality intervention: Change in lifestyle and food consumption is considered to be the leading factor for the rise of obesity and metabolic disorders within the global population. For instance, the report published by the Centers for Disease Control and Prevention, 42.5% of the adults living in the U.S. are dealing with the health risk of obesity, that pushed the demand for cosmetic as well as medical solutions for fat loss.
  Adoption of the minimally invasive technology enables the market to deliver a higher rate of success. As per the study of the AHRQ, hospital stay is reduced by 36% with the help of minimally invasive surgery and leads to saving an expense of 119 million every year. The usage of portable devices and conducting the in-office procedures led to quality service and gained patient reliance.

• Expanded spending: Better research and development are conducted with the availability of financial resources that help to elevate the performance of the particular market. Government as well as private spending made to expand the efficacy of the liposuction surgery devices is a prominent growth driver. For instance, Medicare spending is expanded up to approximately USD 285 million for liposuction-related procurement in 2023. Spending leaped over 10% YoY through a higher rate of medical coverage in the reconstructive cases. Private organization spending also helped the market to boost through the financial plans provided to the patients to cope with the surgery expense and raise accessibility of the market.

Manufacturing Strategies to Ensure Liposuction Surgery Devices Market Expansion
The leading manufacturers expanded the market in the global liposuction surgery device market based on three core strategies. Product innovation is prioritized to achieve higher patient outcomes. For instance, InMode focused on sustainable innovation and developed an energy-based device (BodyTite RFAL system) that led to growth in revenue accumulation. A growth in the market share is experienced of approximately 17.5% in the U.S., which generated additional USD 222 million revenue for the company.  The acquisition strategy is implemented by Johnson & Johnson to expand their liposuction surgery market in the EU and the Asia Pacific market. Mentor is acquired Johnson&Johnson that raised the additional revenue to 183 million. Cost-optimized manufacturing and regulatory agility are the key factors that have the potential for the future growth of the liposuction surgery devices.

Revenue Opportunities for Manufacturers

Key Market Dynamics for Historical Patient Growth

The global market of liposuction surgery devices experienced growth within the period of 2014-2024. The factors that majorly pushed the market growth include a rise in the aging population, a trend of aesthetic consciousness, and higher adoption of minimally invasive technologies. Expansion of Medicare is one of the leading factors that raised patient access in the U.S. liposuction surgery market and created a high demand for technological devices. This resulted in the growth of the patient with a CAGR of 9.7% and helped the market to flourish in the global market.

Private insurance coverage equally helped the German and France markets of the liposuction surgery market and resulted in a sales surge. The emerging market in the Asia Pacific region for liposuction surgery devices is boosted by the growth of medical tourism, specifically in China and India. Three prominent opportunities that manufacturers have availed include insurance-reimbursed procurement, higher adoption of portable devices, and localizing assembly.   

Historical Patient Growth (2014-2024):

Challenge

• Regulatory delay and price cap control: The Introduction of new products and advancement of the market performance are dependent on the approval received. Regulatory delay for the clearance leads to financial loss and low market scalability. For instance, newly introduced safety testing rules by the PMDA of Japan resulted in a delay in the clearance approval by approximately eight months. This led Sciton to experience a loss of over USD 45 million while introducing their new product, laser lipo, in 2023. Government intervention in the pricing cap fixation is one of the leading threats that limits the capital accumulation rate for the business and slow down research and development in the concerned market. For instance, the EU price cap regulation limited the price of the liposuction devices to less than €1,300 for each procedure.